Yes I do see some up-side but we are still at the stage where we are cleaning up all our toxic debts. The float btw is almost locked up. I plan to buy some within next week or so. I don't think the company wants to increase their authorized shares anymore than what they currently have, which is why they are seeking these non-toxic financing agreements (Dawson, Dinosaur).
The 10Q hasn't changed much, except for the fact that the float has gone up and I think that was expected from every investor. Revenues have increased, but only slightly. But we are at $150K for the year. Which is not bad, but there is room for improvement there.
The catalysts still remain the same
- Patents
- JV expectations (Why did all the convertible shareholders all convert in October?) What do they know that we don't know?
- Licensing agreements -- Revenues are crucial, as we all know.
- Non-toxic financing agreements
- PR campaign
- INDs update
With regards to a reverse split, we know from the YA agreement that this is not possible until march, and it would not be of benefit to SVFC.
I was actually very surprised as to how quickly we recovered from the No Bid situation.